Koru Medical Systems, Inc. filed a Form S-3 shelf registration statement with the U.S. Securities and Exchange Commission on November 13, 2026, seeking to register up to $100,000,000 in securities for potential future offerings.

Key Highlights

  • Total shelf size: Up to $100,000,000 in securities may be offered, issued, and sold from time to time under the registration statement.
  • Security types covered: The registration covers common stock, preferred stock, debt securities, and warrants, in any combination.
  • Shelf mechanism: The filing uses a Rule 415 "shelf" registration process, allowing sales on a continuous or delayed basis after the statement becomes effective.
  • Distribution methods: Securities may be sold directly to investors, through designated agents, or through underwriters or dealers, according to the filing.
  • Prospectus supplement required: The filing states that this prospectus may not be used to consummate a sale of any securities unless accompanied by a prospectus supplement.
  • Company classification: Koru Medical identifies itself as a non-accelerated filer and a smaller reporting company in the registration statement.

Koru Medical Systems Registers Broad Securities Shelf Up to $100 Million

Koru Medical Systems, Inc. (NASDAQ:KRMD), a Delaware-incorporated company headquartered at 100 Corporate Drive, Mahwah, New Jersey 07430, filed a Form S-3 shelf registration statement with the SEC on November 13, 2026. According to the filing, the company may sell up to $100,000,000 of securities "from time to time and in one or more offerings" using the shelf mechanism available under Rule 415 of the Securities Act of 1933.

The registration covers four categories of securities: common stock, preferred stock, debt securities, and warrants. The filing also notes that securities issuable upon conversion, redemption, repurchase, exchange, or exercise of any registered securities, including any applicable anti-dilution provisions, may also be offered. The company disclosed that specific terms of each offering will be set out in separate prospectus supplements, which may also add, update, or change information contained in the base prospectus. Pricing, net proceeds, and details about any agents or underwriters will likewise appear in those supplements.

The filing identifies Thomas Adams, Chief Financial Officer, as the agent for service. The registration statement notes that it remains subject to completion and that the securities may not be sold until the registration statement becomes effective. The company cautions that "investing in our securities involves a high degree of risk" and directs prospective purchasers to review risk factors described in the prospectus and any applicable supplement. The filing was listed as "Subject to Completion, Dated November 13, 2026," and the company reserved the right to amend the registration statement as needed to delay its effective date.

What Was Disclosed

Koru Medical Systems filed a shelf registration statement to register up to $100,000,000 in common stock, preferred stock, debt securities, and warrants. No specific offering has been launched; each future sale will be detailed in a separate prospectus supplement.